Surfactant medication for acute respiratory distress syndrome

Thorax

Volumn 52, Issue SUPPL. 3, 1997, Pages

  Baudouin, Simon V ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CORTICOSTEROID; DIPALMITOYLPHOSPHATIDYLCHOLINE; KETOCONAZOLE; LUNG SURFACTANT; METHYLPREDNISOLONE; PLACEBO; PROSTAGLANDIN E1;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ARACHIDONIC ACID METABOLISM; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTRACORPOREAL OXYGENATION; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; JET VENTILATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPSIS; TREATMENT OUTCOME;

EID: 0030853814     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2008.s9     Document Type: Article

References (37)

1. Beale R, Grover HR, Smithies M, Bihari D. Acute respiratory distress syndrome ("ARDS"): no more than severe acute lung injury? BMJ 1993;307:1335-9.
2. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994;271:226-33.
3. Nicholas TE, Doyle IR, Berston AD. Surfactant replacement therapy in ARDS: white knight or noise in the system? Thorax 1997;52:195-7.
4. Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996;334: 1417-21.
5. Repine JK. Scientific perspectives on the adult respiratory distress syndrome. Lancet 1992;339:466-72.
6. Cipolle MD, Pasquale MD, Cerra FB. Secondary organ dysfunction. From clinical perspectives to molecular mediators. Crit Care Clin 1993;9:261-98.
7. Fujishima S, Aikawa N. Neutrophil-mediated tissue injury and its modulation. Intensive Care Med 1995;21:277-85.
8. Donahoe M, Rogers RM. An anecdote is an anecdote is an anecdote ... but a clinical trial is data. Am J Respir Crit Care Med 1994;149:243-4.
9. Stoller JK, Kacmarek RM. Ventilatory strategies in the management of the adult respiratory distress syndrome. Clin Chest Med 1990;11:755-72.
10. Marini JJ. Lung mechanics in the adult respiratory distress syndrome: recent conceptual advances and implications for management. Clin Chest Med 1990;11:673-90.
11. Baudouin SV. Overview of the effects of mechanical ventilation on the pulmonary circulation. In: Peacock AJ, ed. Pulmonary circulation. A handbook for clinicians. London: Chapman and Hall, 1996.
12. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH. Extracorporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective study. JAMA 1971;242:2193-6.
13. 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;149:295-305.
14. Pepe PE, Hudson LD, Carrico CJ. Early application of positive end-expiratory pressure in patients at risk for the adult respiratory-distress syndrome. N Engl J Med 1984;311:281-6.
15. Sasson CSH, Mahutte CK, Light RW. Ventilator modes: old and new. Crit Care Clin 1990;6:605-14.
16. Carlon GC, Howland WS, Ray C, Miodownik S, Griffin JP, Groeger JS. High-frequency jet ventilation. A prospective randomized evaluation. Chest 1983;84:551-9.
17. Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990; 16:372-7.
18. Weg JG, Balk RA, Tharratt RS, Jenkinson SG, Shah JB, Zaccardelli D, et al. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 1994;272:1433-8.
19. Rossaint R, Pappert D, Falke K. Nitric oxide and the pulmonary circulation. Curr Opin Crit Care 1996;2:29-34.
20. Moore FA, Moore FA. Evolving concepts in the pathogenesis of post injury multiple organ failure. Surg Clin North Am 1995;75:257-77.
21. Ahmed NA, Christou NV, Meakins JL. The systemic inflammatory response syndrome and the critically ill surgical patient. Curr Opin Crit Care 1995;1:240-305.
22. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993;341:643-7.
23. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. High-dose corticosteroids in patients with the adult respiratory-distress syndrome. N Engl J Med 1987;317:1565-70.
24. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineflectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138:62-8.
25. Bone RC, Fisher CJ Jr. Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987;92:1032-6.
26. Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, El Torkey M, Leeper KV. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 1991;100:943-52.
27. Leff JA, Parsons PE, Day CE, Taniguchi N, Jochum M, Fritz H, et al. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993;341:777-80.
28. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med 1992;20:918-23.
29. Yu M, Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993;21: 1035-42.
30. Bone RC, Slotman G, Maunder R, Silverman H, Hyers TM, Kerstein MD, et al. Randomized double-blind, multi-centre study of prosta- glandin E, in patients with the adult respiratory distress syndrome. Prostaglandin E, Study Group. Chest 1989;96:114-9.
31. Stewart M, Thiel M, Hogg N. Leukocyte integrins. Curr Opin Cell Biol 1995;7:690-6.
32. Wortel CH, Doerschuk CM. Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome. New Horizons 1993;1:631-7.
33. 1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med 1996;24:10-15.
34. Pallares LC, Evans TW. Oxygen transport in the critically ill. Respir Med 1992;86:289-95.
35. Hayes MA, Timmins AC, Yau EHS, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994;330:1717-22.
36. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, et al. A trial of goal-orientated hemodynamic therapy in critically ill patients. N Engl J Med 1995;333:1025-32.
37. Mitchell JP, Schuller D, Calandrino FS, Schuster DP. Improved out-come based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rez Respir Dis 1992;145:990-8.